{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:07:09Z","timestamp":1780355229092,"version":"3.54.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Researchers Supporting Project","award":["RSP-2019\/111"],"award-info":[{"award-number":["RSP-2019\/111"]}]},{"name":"King Saud University, Riyadh, Sau"},{"name":"di Arabia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To enhance bioavailability of timolol (TML) and utilize alternatives for traditional eye drops for more patient compliance, this study was aiming to develop biodegradable orally dissolving strips (ODSs) of TML for treatment of primary open-angle glaucoma (POAG).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Novel ODSs of TML were formulated and optimized using solvent casting method according to full factorial design (31.22). TML ODSs were characterized with respect to many parameters. In-vivo test was carried out using four groups of 24 New Zealand albino rabbits. POAG was induced by subconjunctival treatment of betamethasone. Histopathological examination and oxidative stress markers assay were carried out.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>The optimized formula (F9) exhibited a remarkably 15-s disintegration time and 96% dissolution rate after 10 min. The results revealed a potent significant inhibitory effect of the optimized TML ODS to reduce IOP in induced rabbits in comparison with control rabbits and TML eye drops-treated rabbits. The formula showed also high activity against oxidative stress and absence of histopathological changes in iridocorneal angle and cornea.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The ODSs could be a promising alternative delivery system for eye drops with more compliance to enhance delivery and therapeutic activity of TML in treatment of POAG.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jphp.13239","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T12:24:52Z","timestamp":1584188692000},"page":"682-698","source":"Crossref","is-referenced-by-count":19,"title":["Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits"],"prefix":"10.1093","volume":"72","author":[{"given":"Yasmin A","family":"El-Feky","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, Modern University for Technology and Information (MTI) , Cairo,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia A","family":"Mostafa","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA) , Giza,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5521-4901","authenticated-orcid":false,"given":"Majid M","family":"Al-Sawahli","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, Faculty of Pharmacy, Kafr Elsheikh University , Kafr Elsheikh,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania Farag A","family":"El-Telbany","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Pharmacy, Modern University for Technology and Information (MTI) , Cairo,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin","family":"Zakaria","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Kafr Elsheikh University , Kafr Elsheikh,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M","family":"Fayez","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, October University for Modern Sciences and Arts (MSA) , Giza,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7376-7411","authenticated-orcid":false,"given":"Kawkab A","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Veterinary Medicine, Cairo University , Giza,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtesam M","family":"Alolayan","sequence":"additional","affiliation":[{"name":"Department of Zoology, College of Science, King Saud University , Riyadh,","place":["Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia Farag A","family":"El-Telbany","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, Modern University for Technology and Information (MTI) , Cairo,","place":["Egypt"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"2024103012351582200_jphp13239-cit-0001","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.3390\/ijms19092830","article-title":"Ocular drug delivery: role of degradable polymeric nanocarriers for ophthalmic application","volume":"19","author":"Tsai","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2024103012351582200_jphp13239-cit-0002","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"2024103012351582200_jphp13239-cit-0003","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-018-0126-8","article-title":"Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma","volume":"50","author":"Khawaja","year":"2018","journal-title":"Nat Genet"},{"key":"2024103012351582200_jphp13239-cit-0004","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-158-4-201302190-00008","article-title":"Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the U.S. Preventive Services Task Force","volume":"158","author":"Boland","year":"2013","journal-title":"Ann Intern Med"},{"key":"2024103012351582200_jphp13239-cit-0005","first-page":"701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"2002","author":"Kass","year":"1960","journal-title":"Arch Ophthalmol"},{"key":"2024103012351582200_jphp13239-cit-0006","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coph.2012.09.003","article-title":"Ocular perfusion pressure and ocular blood flow in glaucoma","volume":"13","author":"Cherecheanu","year":"2013","journal-title":"Curr Opin Pharmacol"},{"key":"2024103012351582200_jphp13239-cit-0007","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.icu.0000156134.38495.0b","article-title":"Blood flow in glaucoma","volume":"16","author":"Grieshaber","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"2024103012351582200_jphp13239-cit-0008","first-page":"849","article-title":"Dysfunctional regulation of ocular blood flow: a risk factor for glaucoma?","volume":"2","author":"Moore","year":"2008","journal-title":"Clin Ophthalmol"},{"key":"2024103012351582200_jphp13239-cit-0009","first-page":"592","article-title":"Ischemic model of optic nerve injury","volume":"103","author":"Cioffi","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"key":"2024103012351582200_jphp13239-cit-0010","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/archopht.122.10.1517","article-title":"Chronic ischemia induces regional axonal damage in experimental primateoptic neuropathy","volume":"122","author":"Cioffi","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"2024103012351582200_jphp13239-cit-0011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11095-018-2557-4","article-title":"Glaucoma-next generation therapeutics: impossible to possible","volume":"36","author":"Adams","year":"2019","journal-title":"Pharm Res"},{"key":"2024103012351582200_jphp13239-cit-0012","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.07.017","article-title":"A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers","volume":"363","author":"Li","year":"2008","journal-title":"Int J Pharm"},{"key":"2024103012351582200_jphp13239-cit-0013","first-page":"87","article-title":"Design, development and evaluation of controlled release levobunolol hydrochloride ocular inserts for glaucoma therapy","volume":"3","author":"Manjunatha","year":"2012","journal-title":"J Chronother Drug Deliv"},{"key":"2024103012351582200_jphp13239-cit-0014","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1201\/9780203912072","volume-title":"Overview of Ocular Drug Delivery. Ophthalmic Drug Delivery Systems","author":"Mitra","year":"2003","edition":"2nd edn"},{"key":"2024103012351582200_jphp13239-cit-0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2165\/00003495-197917010-00002","article-title":"Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma","volume":"17","author":"Heel","year":"1979","journal-title":"Drugs"},{"key":"2024103012351582200_jphp13239-cit-0016","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/eye.2011.82","article-title":"Novel drug delivery systems for glaucoma","volume":"25","author":"Lavik","year":"2011","journal-title":"Eye"},{"key":"2024103012351582200_jphp13239-cit-0017","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jare.2016.07.003","article-title":"Improved bioavailability of timolol maleate via transdermal transfersomal gel: Statistical optimization, characterization, and pharmacokinetic assessment","volume":"7","author":"Morsi","year":"2016","journal-title":"J Adv Res"},{"key":"2024103012351582200_jphp13239-cit-0018","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2017.06.075","article-title":"Enhancement and inhibition effects on the corneal permeability of timolol maleate: Polymers, cyclodextrins and chelating agents","volume":"529","author":"Rodr\u00edguez","year":"2017","journal-title":"Int J Pharm"},{"key":"2024103012351582200_jphp13239-cit-0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.colsurfb.2017.12.015","article-title":"Orally-dissolving film for sublingual and buccal delivery of ropinirole","volume":"163","author":"Lai","year":"2018","journal-title":"Colloids Surf B"},{"key":"2024103012351582200_jphp13239-cit-0020","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1517\/17425247.2012.676040","article-title":"Recent developments in buccal and sublingual delivery systems","volume":"9","author":"Senel","year":"2012","journal-title":"Exp Opin Drug Deliv"},{"key":"2024103012351582200_jphp13239-cit-0021","volume-title":"Nanocarriers for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery","author":"Mohapatra","year":"2018"},{"key":"2024103012351582200_jphp13239-cit-0022","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1167\/iovs.09-4867","article-title":"Distribution of ocular perfusion pressure and its relationship with open-angle glaucoma: the Singapore Malay eye study","volume":"51","author":"Zheng","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024103012351582200_jphp13239-cit-0023","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1211\/jpp.62.04.0018","article-title":"Comparative investigations on different polymers for the preparation of fast-dissolving oral films","volume":"62","author":"Garsuch","year":"2010","journal-title":"J Pharm Pharmacol"},{"key":"2024103012351582200_jphp13239-cit-0024","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2012.11.019","article-title":"In vitro techniques to evaluate buccal films","volume":"166","author":"Nair","year":"2013","journal-title":"J Controlled Release"},{"key":"2024103012351582200_jphp13239-cit-0025","first-page":"9","article-title":"Orally fast dissolving films: innovations in formulation and technology","volume":"9","author":"Bhyan","year":"2011","journal-title":"Int J Pharm Sci Rev Res"},{"key":"2024103012351582200_jphp13239-cit-0026","first-page":"20","article-title":"Mouth dissolving films: innovative vehicle for oral drug delivery","volume":"9","author":"Ghodake","year":"2013","journal-title":"Polymer"},{"key":"2024103012351582200_jphp13239-cit-0027","first-page":"899","article-title":"Mouth dissolving films: a review","volume":"4","author":"Smriti","year":"2013","journal-title":"Int J Pharma Bio Sci"},{"key":"2024103012351582200_jphp13239-cit-0028","first-page":"53","article-title":"Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties","volume":"2","author":"Peh","year":"1999","journal-title":"J Pharm Pharm Sci"},{"key":"2024103012351582200_jphp13239-cit-0029","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.msec.2016.07.023","article-title":"Gelatin\/hydroxypropyl methylcellulose matrices\u2014polymer interactions approach for oral disintegrating films","volume":"69","author":"Tedesco","year":"2016","journal-title":"Mater Sci Eng C"},{"key":"2024103012351582200_jphp13239-cit-0030","first-page":"280","article-title":"Insights into polymers: film formers in mouth dissolving films","volume":"3","author":"Nagar","year":"2011","journal-title":"Drug Invent Today"},{"key":"2024103012351582200_jphp13239-cit-0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/392783","article-title":"Design optimization and in vitro-in vivo evaluation of orally dissolving strips of clobazam","volume":"2014","author":"Bala","year":"2014","journal-title":"J Drug Deliv"},{"key":"2024103012351582200_jphp13239-cit-0032","first-page":"459","article-title":"Photopic negative response in diagnosis of glaucoma: an experimental study in glaucomatous rabbit model","volume":"8","author":"ElGohary","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"2024103012351582200_jphp13239-cit-0033","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1463-5224.2011.00879.x","article-title":"Comparison of a rebound and an applanation tonometer for measuring intraocular pressure in normal rabbits","volume":"14","author":"Pereira","year":"2011","journal-title":"Vet Ophthalmol"},{"key":"2024103012351582200_jphp13239-cit-0034","volume-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"key":"2024103012351582200_jphp13239-cit-0035","first-page":"96","article-title":"Formulation and evaluation of repaglinide buccal tablet: ex vivo bioadhesion study and ex vivo permeability study","volume":"4","author":"Biswal","year":"2014","journal-title":"J Appl Pharm Sci"},{"key":"2024103012351582200_jphp13239-cit-0036","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jsps.2015.02.024","article-title":"Orally disintegrating films: a modern expansion in drug delivery system","volume":"24","author":"Irfan","year":"2016","journal-title":"Saudi Pharm J"},{"key":"2024103012351582200_jphp13239-cit-0037","first-page":"291","article-title":"A short review on \u201cA novel approach in oral fast dissolving drug delivery system and their patents\u201d","volume":"5","author":"Siddiqui","year":"2011","journal-title":"Adv Biol Res"},{"key":"2024103012351582200_jphp13239-cit-0038","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.foodhyd.2008.07.017","article-title":"Effects of various plasticizers on mechanical and water vapor barrier properties of gelatin films","volume":"23","author":"Cao","year":"2009","journal-title":"Food Hydrocolloids"},{"key":"2024103012351582200_jphp13239-cit-0039","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ejpb.2008.06.032","article-title":"Fast dissolving films made of maltodextrins","volume":"70","author":"Cilurzo","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012351582200_jphp13239-cit-0040","first-page":"69","article-title":"Fast dissolving films: a novel approach to oral drug delivery","volume":"2","author":"Aggarwal","year":"2011","journal-title":"Int Res J Pharm"},{"key":"2024103012351582200_jphp13239-cit-0041","volume-title":"Centre for Drug Evaluation and Research (CDER) Guidance for industry: orally disintegrating tablets","author":"Health UDo, Services H","year":"2007"},{"key":"2024103012351582200_jphp13239-cit-0042","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ajps.2017.07.006","article-title":"Buccal administration of mucoadhesive blend films saturated with propranolol loaded nanoparticles","volume":"13","author":"Kraisit","year":"2018","journal-title":"Asian J Pharm Sci"},{"key":"2024103012351582200_jphp13239-cit-0043","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jddst.2017.12.020","article-title":"Role of plasticizer in membrane coated extended release oral drug delivery system","volume":"44","author":"Khatri","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"2024103012351582200_jphp13239-cit-0044","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jsps.2014.11.012","article-title":"Effect of HPMC and mannitol on drug release and bioadhesion behavior of buccal discs of buspirone hydrochloride: in-vitro and in-vivo pharmacokinetic studies","volume":"23","author":"Jaipal","year":"2015","journal-title":"Saudi Pharm J"},{"key":"2024103012351582200_jphp13239-cit-0045","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/2230-973X.82417","article-title":"Formulation and evaluation of fast dissolving films of levocetirizine di hydrochloride","volume":"1","author":"Prabhu","year":"2011","journal-title":"Int J Pharm Invest"},{"key":"2024103012351582200_jphp13239-cit-0046","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijpharm.2017.07.028","article-title":"Improvement of the surface hydrophilic properties of naproxen particles with addition of hydroxypropylmethyl cellulose and sodium dodecyl sulphate: In vitro and in vivo studies","volume":"529","author":"Garc\u00eda-Herrero","year":"2017","journal-title":"Int J Pharm"},{"key":"2024103012351582200_jphp13239-cit-0047","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jddst.2017.10.012","article-title":"Formulation of unidirectional buccal tablet of Mirtazapine: an in vitro and ex vivo evaluation","volume":"43","author":"Koradia","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"2024103012351582200_jphp13239-cit-0048","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0006-8993(02)03372-3","article-title":"Protective effects of timolol against the neuronal damage induced by glutamate and ischemia in the rat retina","volume":"958","author":"Goto","year":"2002","journal-title":"Brain Res"},{"key":"2024103012351582200_jphp13239-cit-0049","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.brainresbull.2006.07.009","article-title":"Nitric oxide synthase in retina and optic nerve head of rat with increased intraocular pressure and effect of timolol","volume":"70","author":"Vidal","year":"2006","journal-title":"Brain Res Bull"},{"key":"2024103012351582200_jphp13239-cit-0050","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/S0039-6257(99)00054-5","article-title":"Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of \u03b2-blockers","volume":"43","author":"Gross","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"2024103012351582200_jphp13239-cit-0051","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1167\/iovs.12-11256","article-title":"Reduction in blood glutathione levels occurs similarly in patients with primary-open angle or normal tension glaucoma","volume":"54","author":"Gherghel","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024103012351582200_jphp13239-cit-0052","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.eye.6702737","article-title":"Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course","volume":"22","author":"Izzotti","year":"2008","journal-title":"Eye"},{"key":"2024103012351582200_jphp13239-cit-0053","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archophthalmol.2010.324","article-title":"Ability of dorzolamide hydrochloride and timolol maleate to target mitochondria in glaucoma therapy","volume":"129","author":"Sacc\u00e0","year":"2011","journal-title":"Arch Ophthalmol"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.13239","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jphp.13239","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jphp.13239","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/72\/5\/682\/60226362\/jphp13239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/72\/5\/682\/60226362\/jphp13239.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:00:20Z","timestamp":1730311220000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/72\/5\/682\/6122108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,1]]},"published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jphp.13239","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"value":"2042-7158","type":"electronic"},{"value":"0022-3573","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2020,5,1]]}}}